Jay D. Kranzler, CEO at CYPRESS BIOSCIENCE INC (CYPB), sold 5,000 shares at $7.96 ($40K) on 2007-02-26, disclosed to the SEC on 2007-02-27.
Scheduled sale ($40k) by CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.94 | 300 | $2K | 5.9% |
| 2 | $7.95 | 138 | $1K | 2.7% |
| 3 | $7.96 | 362 | $3K | 7.2% |
| 4 | $7.97 | 100 | $797 | 2.0% |
| 5 | $7.98 | 700 | $6K | 13.9% |
| 6 | $7.99 | 1,000 |
| $8K |
| 19.9% |
| 7 | $8.01 | 400 | $3K | 8.0% |
| 8 | $8.02 | 100 | $802 | 2.0% |
| 9 | $8.03 | 300 | $2K | 6.0% |
| 10 | $8.04 | 500 | $4K | 10.0% |
| 11 | $8.06 | 100 | $806 | 2.0% |
| 12 | $8.07 | 100 | $807 | 2.0% |
| 13 | $8.08 | 100 | $808 | 2.0% |
| 14 | $8.09 | 400 | $3K | 8.1% |
| 15 | $8.11 | 100 | $811 | 2.0% |
| 16 | $8.12 | 100 | $812 | 2.0% |
| 17 | $8.15 | 100 | $815 | 2.0% |
| 18 | $8.16 | 100 | $816 | 2.0% |
| Total | $8.02 avg | 5,000 | $40K | 100% |
| Filing → |
| CYPB | SELL | 2010-12-29 | $162K | — | Filing → |
| CYPB | SELL | 2010-12-29 | $983K | — | Filing → |
| CYPB | SELL | 2009-08-04 | $652K | — | Filing → |